The day I met Dr.Batra he was very knowledgeable and reassuring
January 2023: The U.S
The ingredients are lightly dosed, the delivery method is unproven, and the cited research doesnt back up the claims made, especially when it comes to GLP-1-related effects
Clin Pharmacokinet 36:111 Marbury TC, Flint A, Jacobsen JB, Derving Karsbol J, Lasseter K (2017) Pharmacokinetics and tolerability of a single dose of semaglutide, a human glucagon-like peptide-1 analog, in subjects with and without renal impairment
Dual agonist
An RCT including 85 women with different indications for ICSI who have been supplemented with AOX daily from the cycle preceding ICSI cycle, versus 85 women who were not given any AOX acting as controls, concluded that AOX therapy did not change clinical or laboratory outcomes (225)